REVIR

Serial Number 97196854
602

Registration Progress

Application Filed
Dec 30, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

REVIR

Basic Information

Serial Number
97196854
Filing Date
December 30, 2021
Abandonment Date
April 12, 2023
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 25, 2023
Classes
044

Rights Holder

Revir Therapeutics, Inc.

03
Address
969 G Edgewater Blvd, Suite #185
Foster City, CA 94404

Ownership History

Revir Therapeutics, Inc.

Original Applicant
03
Foster City, CA

Legal Representation

Attorney
Enshan Hong

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

13 events
Date Code Type Description Documents
Apr 25, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Apr 25, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Apr 25, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Oct 11, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 11, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 11, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 4, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 1, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 1, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 1, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 1, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
First Use Anywhere: May 10, 2021
First Use in Commerce: May 10, 2021

Additional Information

Design Mark
The mark consists of stylized wording "REVIR".

Classification

International Classes
044